Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 78
Number Thumbnail Title Author Date Votes Views
58 Prestige Biopharma IDC Signs Joint Research Agreement for Antibody Therapeutic Development Targeting Cancer Cachexia
김** | 2026.05.19 | Votes 0 | Views 3409
김** 2026.05.19 0 3409
57 Prestige BioPharma IDC Successfully Attracts Investment for Co-Development Partner
we******** | 2026.05.13 | Votes 0 | Views 2334
we******** 2026.05.13 0 2334
56 IDC Expands Asset Value to Over 200 Billion KRW… "Accelerating Commercialization on the Back of Financial Stability"
we******** | 2026.05.11 | Votes 0 | Views 2496
we******** 2026.05.11 0 2496
55 BJFEZ Expands ‘Insight Trip’ Program to High School Students: “Discovering the Future On-Site”
we******** | 2026.04.29 | Votes 0 | Views 1806
we******** 2026.04.29 0 1806
54 Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform ‘IDC224’
김** | 2026.04.21 | Votes 0 | Views 3396
김** 2026.04.21 0 3396
53 BJFEZ Advances Open Innovation Campus for AI-Driven Drug Development
김** | 2026.04.13 | Votes 0 | Views 1946
김** 2026.04.13 0 1946
52 Prestige Biopharma's Avastin Biosimilar HD204 Nears Regulatory Approval and Commercialization
김** | 2026.03.24 | Votes 0 | Views 4457
김** 2026.03.24 0 4457
51 Prestige Biopharma IDC Signs Strategic Research Collaboration Agreement with Pusan National University Medical Research Institu
김** | 2026.02.25 | Votes 0 | Views 2391
김** 2026.02.25 0 2391
50 Prestige Biopharma IDC Files Patent for Bispecific Antibody Targeting Cytokine Storm–Related Inflammatory Diseases
김** | 2026.02.24 | Votes 0 | Views 1730
김** 2026.02.24 0 1730
49 Prestige Biopharma IDC Obtains ISO 9001 Certification for Global Quality Management System
김** | 2026.01.29 | Votes 0 | Views 1567
김** 2026.01.29 0 1567

Read Prestige news >>

FY2026
Shareholder Letter
FY2026
Shareholder Letter